Dr. Chris J Coffini, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 701 S Church St, Watertown, WI 53094 Phone: 920-261-9225 Fax: 920-261-7010 |
Dr. Lexi Derry, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 123 Hospital Dr, Watertown, WI 53098 Phone: 202-618-2259 Fax: 920-261-5343 |
Uwhp Wrmc Center For Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 123 Hospital Dr, Suite 1002, Watertown, WI 53098 Phone: 920-261-8225 Fax: 920-261-5343 |
Dr. Alicja Janina Fitzgerald, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 701 S Church St, Watertown, WI 53094 Phone: 920-261-9225 |
Dr. Michael Joseph Bannon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1500 S Church St, Watertown, WI 53094 Phone: 920-261-9225 |
Kellye Zaporski, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 701 S Church St, Watertown, WI 53094 Phone: 920-261-9225 |
Desiree Monik Herron, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1640 S Church St, Watertown, WI 53094 Phone: 920-390-2971 Fax: 920-390-2974 |
Claris Eyecare Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1307 Memorial Dr, Watertown, WI 53098 Phone: 920-988-3605 |
Dr. Julie Marie Zoellick, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1307 Memorial Dr, Watertown, WI 53098 Phone: 920-968-7546 Fax: 920-328-1442 |
Carolyn T Schneider-donley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 622 N. Church Street, Watertown, WI 53098 Phone: 920-262-9200 Fax: 920-262-8915 |
John R Anslinger, OD Optometrist Medicare: Medicare Enrolled Practice Location: 123 Hospital Dr, Ste 1002, Watertown, WI 53098 Phone: 920-261-8225 Fax: 920-261-5343 |
Watertown Vision, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1640 S Church St, Watertown, WI 53094 Phone: 920-390-2971 Fax: 920-390-2974 |
Eye Physicians Of Watertown Sc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 123 Hospital Drive, Suite 1002, Watertown, WI 53098 Phone: 920-261-8225 Fax: 920-261-5343 |
News Archive
The first protein engineered to help control bleeding episodes in patients with severe von Willebrand disease (vW disease) has been shown to be safe and effective, according to results of a Phase III trial.
Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth.
The widespread use of a simplified clinical tool to estimate future coronary risk could lead to the classification of millions of Americans into different risk groups than when using the original, "gold-standard" tool. Millions of patients may have been misclassified into higher-risk groups and therefore potentially over-treated, while others may have ended up in lower-risk groups and therefore potentially under-treated for heart disease. The study-, led by William Gordon from Weill Cornell Medical College in the US and colleagues, is published in the Journal of General Internal Medicine-, published by Springer.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
› Verified 5 days ago